γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct-Reference-Cited by-同舟云学术

γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct

Published:2017-05-24 Issue:7 Volume:9 Page:950-966
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Ran Yong¹^ORCID,Hossain Fokhrul²,Pannuti Antonio²,Lessard Christian B¹,Ladd Gabriela Z³,Jung Joo In¹,Minter Lisa M⁴,Osborne Barbara A⁴,Miele Lucio²,Golde Todd E¹^ORCID

Affiliation:

1. Department of Neuroscience Center for Translational Research in Neurodegenerative Disease, and McKnight Brain Institute College of Medicine University of Florida Gainesville FL USA

2. Department of Genetics and Stanley S. Scott Cancer Center Louisiana State University Health Sciences Center New Orleans LA USA

3. College of Pharmacy University of Florida Gainesville FL USA

4. Department of Veterinary and Animal Sciences and Program in Molecular and Cellular Biology University of Massachusetts Amherst MA USA

Funder

National Cancer Institute

National Institute on Aging

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201607265